Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr;26(2):e147-e154.
doi: 10.3747/co.26.4261. Epub 2019 Apr 1.

A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy

Affiliations

A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy

K Li et al. Curr Oncol. 2019 Apr.

Abstract

Objectives: In cancer patients, chemotherapy-induced peripheral neuropathy (cipn) is a common complication, characterized by pain, loss of sensation, and numbness. Medical treatment for peripheral neuropathies has been shown to be ineffective for cipn. Acupuncture has been shown to be safe and effective in treating cancer-related symptoms and other peripheral neuropathies. For the present review, we aimed to evaluate the efficacy of acupuncture for the treatment of cipn.

Design: Comprehensive searches for relevant studies were conducted in Ovid embase, the Web of Science, Ovid medline, the Cochrane Central Register of Controlled Trials (central), cinahl (ebsco Information Services, Ipswich, MA, U.S.A.), and the ClinicalTrials.gov Web site. References from previous systematic reviews were also searched. Additional trials were found in the reference lists of relevant papers and in searches of Google Scholar and acupuncture-specific Web sites. Included studies were randomized controlled trials (rcts) of any type of acupuncture used to treat patients with cipn.

Results: Three clinical trials (203 participants) were included. Two studies found acupuncture to be effective in alleviating cipn pain and improving quality of life. One study found no benefit in improving neuropathic pain, symptoms, or quality of life. Study quality was variable and included a moderate overall risk of bias.

Conclusions: The evidence is insufficient to recommend acupuncture for the treatment or prevention of cipn. Further research is needed to evaluate the effects of acupuncture in the treatment of cipn. Given that acupuncture is considered safe and might provide relief for patients, it can be considered at the clinician's discretion.

Keywords: Acupuncture; chemotherapy-induced peripheral neuropathy; cipn; integrative oncology; systematic reviews.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES We have read and understood Current Oncology’s policy on disclosing conflicts of interest, and we declare that we have none.

Figures

FIGURE 1
FIGURE 1
PRISMA flow chart for the study selection process.
FIGURE 2
FIGURE 2
Risk-of-bias assessment for the included studies. Studies were evaluated using the Cochrane Risk of Bias tool and were classified under each category as low, high, or unclear risk of bias.

References

    1. Starobova H, Vetter I. Pathophysiology of chemotherapy-induced peripheral neuropathy. Front Mol Neurosci. 2017;10:174. doi: 10.3389/fnmol.2017.00174. - DOI - PMC - PubMed
    1. Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Pain. 2014;155:2461–70. doi: 10.1016/j.pain.2014.09.020. - DOI - PubMed
    1. Gordon BS, Gbadamosi B, Jaiyesimi IA. The relationship between chemotherapy-induced neuropathy and quality of life in breast cancer survivors [abstract e22111] J Clin Oncol. 2018;36 doi: 10.1200/JCO.2018.36.15_suppl.e22111. [Available online at: http://ascopubs.org/doi/abs/10.1200/JCO.2018.36.15_suppl.e22111; cited 13 January 2019] - DOI - DOI
    1. Mols F, Beijers T, Vreugdenhil G, Van De Poll-Franse L. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review. Support Care Cancer. 2014;22:2261–9. doi: 10.1007/s00520-014-2255-7. - DOI - PubMed
    1. Tofthagen C, Donovan K, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors. Support Care Cancer. 2013;21:3307–13. doi: 10.1007/s00520-013-1905-5. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances